These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 17166789)
1. Multiple sclerosis: new insights and therapeutic progress. Miller D Lancet Neurol; 2007 Jan; 6(1):5-6. PubMed ID: 17166789 [No Abstract] [Full Text] [Related]
2. [Multiple sclerosis, the therapeutic arsenal of today and tomorrow]. Zéphir H Soins; 2009 Nov; (740):39-41. PubMed ID: 20014532 [No Abstract] [Full Text] [Related]
3. Fingolimod and multiple sclerosis: four cautionary tales. Bourdette D; Gilden D Neurology; 2012 Nov; 79(19):1942-3. PubMed ID: 23035058 [No Abstract] [Full Text] [Related]
4. Multiple sclerosis: closing in on an oral treatment. Martin R Nature; 2010 Mar; 464(7287):360-2. PubMed ID: 20237554 [No Abstract] [Full Text] [Related]
5. Severe multiple sclerosis relapse under fingolimod therapy: incident or coincidence? Castrop F; Kowarik MC; Albrecht H; Krause M; Haslinger B; Zimmer C; Berthele A; Hemmer B Neurology; 2012 Mar; 78(12):928-30. PubMed ID: 22402856 [No Abstract] [Full Text] [Related]
6. [New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimod]. Komoly S Ideggyogy Sz; 2012 Nov; 65(11-12):421-2. PubMed ID: 23289178 [No Abstract] [Full Text] [Related]
7. [New disease-modifying and symptomatic therapies for multiple sclerosis]. Weise G; Buttmann M MMW Fortschr Med; 2012 Apr; 154(7):64-6. PubMed ID: 22558878 [No Abstract] [Full Text] [Related]
8. Multiple sclerosis poses tough drug development challenges. Senior K Drug Discov Today; 2005 Dec; 10(23-24):1583-4. PubMed ID: 16376813 [No Abstract] [Full Text] [Related]
9. Fingolimod for multiple sclerosis. Pelletier D; Hafler DA N Engl J Med; 2012 Jan; 366(4):339-47. PubMed ID: 22276823 [No Abstract] [Full Text] [Related]
13. New drugs may improve, complicate treatment for multiple sclerosis. Link H; Martin R Nat Med; 2010 Mar; 16(3):272. PubMed ID: 20208513 [No Abstract] [Full Text] [Related]
14. [Disease modifying drugs in multiple sclerosis and pregnancy]. Tur C; Tintoré M; Aguilera C Med Clin (Barc); 2012 Sep; 139(7):316-8. PubMed ID: 22743277 [No Abstract] [Full Text] [Related]
15. [A plan for risk management in the treatment of multiple sclerosis with gilenia (fingolimod)]. Popova NF Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):110-3. PubMed ID: 21916166 [No Abstract] [Full Text] [Related]
16. The curtain is drawn for both natalizumab and fingolimod (FTY720): a new era of multiple sclerosis therapy has arrived. Weissert R Expert Rev Neurother; 2006 Nov; 6(11):1587-90. PubMed ID: 17144774 [No Abstract] [Full Text] [Related]
17. Agency is under fire for refusing to supply details of sudden deaths after first dose of multiple sclerosis drug. Wise J BMJ; 2012 Feb; 344():e1360. PubMed ID: 22362460 [No Abstract] [Full Text] [Related]